The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of the Pfizer booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period between a second dose and a booster shot from six months to five months. Both approvals came from the […]
